A new charitable foundation that will improve cancer care in Europe and beyond is being created by the European Society for Medical Oncology (ESMO), the leading charity in the field of oncology education and training.
The new ESMO Foundation will officially come into existence during ESMOs biennial congress, which is being held in Vienna this year. In the city where Mozart, Beethoven, Schubert, Brahms, and the Strauss family did their most significant work, it is only fitting that a concert should be the event through which the Foundation will be launched. On Saturday, 30 October 2004, the Wiener Virtuosen (Vienna Virtuosi), together with soprano Ildiko Raimondi, will give a special performance at the Wiener Konzerthaus (Vienna Concert House) for ESMO members and guests. These twelve musicians are among the principal players of the Wiener Philharmoniker (Vienna Philharmonic Orchestra), one of the worlds greatest and oldest (1842) symphonic ensembles, whose conductors have included Gustav Mahler, Arturo Toscanini, Bruno Walter, Herbert von Karajan and many other podium giants. And the stunning Wiener Konzerthaus will be an appropriate frame for so important an event in ESMOs history.
The purpose of the new ESMO Foundation is to provide much needed funds for a wide range of activities, with the ultimate aim of making the best treatment available to every cancer patient. "The European Society for Medical Oncology is preparing for the future. It has long been the desire of ESMOs Executive Committee to launch an ESMO Foundation, and the day has finally come," ESMO Past President Prof. Heinz Ludwig says with pride. "ESMOs number one priority is to constantly improve the care and treatment of cancer patients," Ludwig says. "To achieve that goal, substantial financial support is needed. We hope the ESMO Foundation will help to channel the funds needed for fostering education and research to meet our goals."
Gracemarie Bricalli | alfa
GLUT5 fluorescent probe fingerprints cancer cells
20.04.2018 | Michigan Technological University
Scientists re-create brain neurons to study obesity and personalize treatment
20.04.2018 | Cedars-Sinai Medical Center
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
20.04.2018 | Physics and Astronomy
20.04.2018 | Interdisciplinary Research
20.04.2018 | Physics and Astronomy